Delivery Order SPE2DB20D3103-SPE2DB25FP5X1
- Not listed
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- The Defense Logistics Agency awarded a delivery order valued at $7,162.15 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly prescribed for stroke prevention and blood clot treatment, indicating...
- The Defense Logistics Agency awarded a delivery order valued at $45,565.02 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order, which is not set-aside, is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal healthcare systems to prevent blood clots...
- The Defense Logistics Agency awarded a delivery order valued at $3,011.76 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used primarily for stroke prevention and blood clot...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,042.25 for 60 tablets of Eliquis 5 mg on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used for stroke prevention and blood clot treatment in military...
- The Defense Logistics Agency awarded a $37,895.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely used anticoagulant medication prescribed for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $15,735.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for ultimate completion by July 31, 2025, with fulfillment to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely used...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $17,176.10 delivery order from the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count). This firm fixed-price, competitively awarded contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside...
- The Defense Logistics Agency awarded a $25,827.06 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 per package. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5X1Delivery Order
The Defense Logistics Agency awarded a $7,980.37 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be supplied from the vendor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military healthcare and veteran medical systems to prevent blood clots and reduce stroke risk. This delivery order is executed under AmerisourceBergen's $999.99 billion Pharmaceutical Prime Vendor Global Program contract with DLA Troop Support Medical, extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen fulfills medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The contract demonstrates the company's established capability to support military healthcare operations through its comprehensive pharmaceutical distribution network serving Department of Defense medical supply chains globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 7/22/25 |